BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, November 4, 2024, at 8:00 a.m. EST (2:00 p.m. CET) to report its financial ...

The new drug application (NDA) (the "Application") based on the positive results from the pivotal phase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) ...

TROPiCS-03 is a basket study designed to evaluate the efficacy and safety of sacituzumab govitecan, a trophoblast cell-surface antigen 2–directed ADC, in patients with metastatic solid tumors.

5t4滋养层糖蛋白（5t4 oncofetal trophoblast ...

Menopause usually begins between 45 and 55 years of age, but some people may experience it as early as age 35. This is known as early menopause. Treatments for symptoms include supplements and ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Glycosaminoglycans are often deprioritized as ...

This work presents a valuable finding on how the interplay between transcription factors SOX2 and OCT4 establishes the pluripotency network in early mouse embryos. Despite the high quality of the data ...

Here, we developed matched trophoblast (TO) and decidua organoids (DO) from human placentas to define the relative contributions of these cells to antiviral defenses at the maternal-fetal interface.